Pinealon 10 mg
Batch analytics · >99 % purity
Peptides at the center of cognition research
The umbrella term nootropics covers substances examined in cognition research. This category brings together three peptides — Selank, Pinealon and Semax — and sets out their chain lengths, sequences and research fields.
1 kit is a box of 10 identical vials of the same variant.
Research Use Only · Not for consumption · Not for therapy
Pinealon is available at 10 mg per vial, Selank at 5 or 10 mg and Semax at 5, 10 or 30 mg. The product pages list each variant and its specification in detail.
The nootropics field is broad; this category is limited to Selank, Pinealon and Semax. If you want to compare structures and other peptide classes, the peptide overview covers them; the journal goes deeper into individual research topics.
Selank is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and a modified tuftsin analog. Pinealon is a tripeptide with the sequence Glu-Asp-Arg, and Semax is a heptapeptide from ACTH research. So one tripeptide and two heptapeptides with different sequences sit side by side.
The term nootropics refers to substances studied in cognition research. The Cognition category here covers the three peptides Selank, Pinealon and Semax. The classification describes the research field, not an effect of the individual products.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and a modified tuftsin analogue. In research it is considered in connection with GABA-related signaling pathways. Selank is available at 5 or 10 mg per vial.
Selank is a heptapeptide of seven amino acids and a tuftsin analogue. Pinealon is a tripeptide with the sequence Glu-Asp-Arg. Selank is available at 5 or 10 mg per vial, Pinealon at 10 mg per vial.
The category includes Pinealon at 10 mg per vial, Selank at 5 or 10 mg per vial and Semax at 5, 10 or 30 mg per vial. All figures refer to strength per vial. Details on each variant are given on the respective product page.
Batch analytics · >99 % purity